Hodgkin’s Lymphoma (HL)

InPOG-HL19-03

Response-Adapted Management of Childhood Classical Hodgkin Lymphoma (cHL) and Early Response Assessment by Positron Emission and Computerized Tomography (PET-CT) to allow Omission of Radiotherapy in Indian Children with Treated with a Standard of Care Intensified Chemotherapy Regimen.

PI : Dr. Gaurav Narula
View Clinical Trial

INPHOG-HL-26-05

Phase II Study of Bendamustine and Fixed-Dose Nivolumomab in Children with Relapsed or Refractory Hodgkin Lymphoma.

PI : Dr. Shyam Srinivasan
View Clinical Trial

InPOG-HL-15-01

A collaborative study for newly diagnosed childhood Hodgkin’s lymphoma patients in India.

PI : Dr. Jagdish Chandra
View Publication

InPOG-HL-17-02

Prospective Collaborative Study for Relapsed/Refractory Hodgkin Lymphoma.

PI : Dr. Amita Mahajan
View Publication

INPHOG-HL-24-04

Immunotherapeutic strategies in children and adolescents with Hodgkin lymphoma.

PI : Dr. Amita Mahajan
View Publication